Mckesson is a medical distribution company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker MCK on the NYSE exchange.
Mckesson stock last closed at $825.62, up 1.17% from the previous day, and has increased 41.11% in one year. It has overperformed other stocks in the Medical Distribution industry by 0 percentage points. Mckesson stock is currently +44.72% from its 52-week low of $570.51, and -7.81% from its 52-week high of $895.58.
As of Jan 12, 2026, there are 123.43M MCK shares outstanding. The market value of MCK is $101.90B. In the past 24 hours, 367,000 MCK shares were traded.
You need an online brokerage account to access the NYSE market and buy MCK stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal info so you are able to invest in MCK today.
Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new brokerage account.
After you have figured out the best place to buy Mckesson stock, it's critical to research their stock before you buy, so you actually understand the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on MCK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MCK's fair value.
Using relative valuations ratios:
You can access additional valuation analysis on MCK's stock here.
Out of 13 Wall Street analysts who give forecasts on MCK, the consensus analyst rating on Mckesson is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Brian Tanquilut, a top 14% analyst from Jefferies maintains MCK with a strong buy rating and raises their MCK price target from $820.00 to $900.00, on Oct 14, 2025.
Jefferies's Brian Tanquilut raised their price target on Mckesson (NYSE: MCK) by 9.8% from $820 to $900 on 2025/10/14. The analyst maintained their Strong Buy rating on the stock.
After McKesson's 2025 Investor Day, Tanquilut reiterated their strong stance on the stock, citing management's increased long-term EPS growth guidance of 13% to 16% and the reporting divisions' simplicity, which gives investors better insight into McKesson's business lines.
The analyst said the stock is "a compelling buy" at its present forward earnings multiple of 17.6x.
Lisa Gill, a top 19% analyst from JP Morgan maintains MCK with a strong buy rating and raises their MCK price target from $821.00 to $853.00, on Sep 26, 2025.
Elizabeth Anderson, a bottom 16% analyst from Evercore ISI Group maintains MCK with a buy rating and raises their MCK price target from $800.00 to $825.00, on Sep 24, 2025.
Charles Rhyee, a bottom 4% analyst from TD Cowen maintains MCK with a strong buy rating and raises their MCK price target from $830.00 to $864.00, on Sep 24, 2025.
Daniel Grosslight, a bottom 3% analyst from Citigroup maintains MCK with a strong buy rating and raises their MCK price target from $820.00 to $860.00, on Sep 24, 2025.
You can dive deeper into what analysts are saying on the Mckesson stock forecast page.
Last year, MCK earnings were $4.03B. During the past 5 year, MCK's earnings have gone up by 19.92% per year. This was faster than the Medical Distribution industry average of 12.45%.
Last year, MCK revenue was $387.09B. In the past five year, MCK's revenue has grown by 10.57% per year. This was faster than the Medical Distribution industry average of 10.15%.
You can analyze MCK's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at MCK have sold more shares than they have bought.
Thomas L. Rodgers, EVP Chief Strategy BDO of MCK, was the latest MCK insider to sell. They sold $225,265.68 worth of MCK shares on Jan 5, 2026.
Research more about who owns MCK shares here.
Mckesson pays a dividend of 0.37%, compared to the Medical Distribution industry's average dividend yield of 0.62%. If you owned $1,000 of MCK stock, you would have been paid $3.71 last year.
Mckesson dividend payments have consistently grown over the past decade and have remained stable.
Find more data about Mckesson dividend yield and history here.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary options:
Click the Open button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some MCK stock, you'll want to keep up with your new company.
Make a watchlist to track the latest developments regarding your MCK stock.
To reiterate, here are the 6 steps you need to take to buy Mckesson stock right now:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Mckesson, get started below.